Cerus Operating Margin 2010-2025 | CERS
Current and historical operating margin for Cerus (CERS) over the last 10 years. The current operating profit margin for Cerus as of June 30, 2025 is -9.81%.
| Cerus Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $0.22B | $-0.01B | -5.07% |
| 2025-03-31 | $0.21B | $-0.01B | -5.77% |
| 2024-12-31 | $0.20B | $-0.01B | -6.93% |
| 2024-09-30 | $0.20B | $-0.01B | -6.06% |
| 2024-06-30 | $0.19B | $-0.02B | -8.25% |
| 2024-03-31 | $0.19B | $-0.02B | -12.57% |
| 2023-12-31 | $0.19B | $-0.03B | -16.13% |
| 2023-09-30 | $0.18B | $-0.04B | -22.28% |
| 2023-06-30 | $0.18B | $-0.04B | -23.50% |
| 2023-03-31 | $0.18B | $-0.04B | -20.77% |
| 2022-12-31 | $0.19B | $-0.03B | -18.09% |
| 2022-09-30 | $0.19B | $-0.03B | -16.58% |
| 2022-06-30 | $0.18B | $-0.04B | -19.13% |
| 2022-03-31 | $0.17B | $-0.04B | -24.28% |
| 2021-12-31 | $0.16B | $-0.05B | -30.00% |
| 2021-09-30 | $0.14B | $-0.06B | -38.19% |
| 2021-06-30 | $0.13B | $-0.06B | -44.27% |
| 2021-03-31 | $0.12B | $-0.06B | -49.17% |
| 2020-12-31 | $0.12B | $-0.06B | -50.43% |
| 2020-09-30 | $0.11B | $-0.06B | -56.07% |
| 2020-06-30 | $0.10B | $-0.06B | -62.38% |
| 2020-03-31 | $0.10B | $-0.07B | -67.71% |
| 2019-12-31 | $0.09B | $-0.07B | -70.97% |
| 2019-09-30 | $0.09B | $-0.07B | -74.71% |
| 2019-06-30 | $0.08B | $-0.06B | -74.70% |
| 2019-03-31 | $0.08B | $-0.06B | -72.50% |
| 2018-12-31 | $0.08B | $-0.06B | -73.33% |
| 2018-09-30 | $0.07B | $-0.05B | -68.92% |
| 2018-06-30 | $0.07B | $-0.05B | -72.06% |
| 2018-03-31 | $0.06B | $-0.05B | -86.67% |
| 2017-12-31 | $0.05B | $-0.06B | -111.76% |
| 2017-09-30 | $0.04B | $-0.06B | -138.64% |
| 2017-06-30 | $0.04B | $-0.06B | -153.66% |
| 2017-03-31 | $0.04B | $-0.06B | -164.10% |
| 2016-12-31 | $0.04B | $-0.06B | -156.41% |
| 2016-09-30 | $0.04B | $-0.06B | -164.86% |
| 2016-06-30 | $0.04B | $-0.06B | -180.00% |
| 2016-03-31 | $0.04B | $-0.06B | -177.14% |
| 2015-12-31 | $0.04B | $-0.06B | -174.29% |
| 2015-09-30 | $0.04B | $-0.06B | -168.57% |
| 2015-06-30 | $0.04B | $-0.05B | -145.95% |
| 2015-03-31 | $0.04B | $-0.05B | -132.43% |
| 2014-12-31 | $0.04B | $-0.04B | -118.92% |
| 2014-09-30 | $0.04B | $-0.04B | -108.33% |
| 2014-06-30 | $0.04B | $-0.04B | -97.30% |
| 2014-03-31 | $0.04B | $-0.03B | -84.21% |
| 2013-12-31 | $0.04B | $-0.03B | -70.00% |
| 2013-09-30 | $0.04B | $-0.02B | -57.14% |
| 2013-06-30 | $0.04B | $-0.02B | -51.28% |
| 2013-03-31 | $0.04B | $-0.02B | -47.37% |
| 2012-12-31 | $0.04B | $-0.02B | -48.65% |
| 2012-09-30 | $0.04B | $-0.02B | -47.22% |
| 2012-06-30 | $0.04B | $-0.02B | -43.24% |
| 2012-03-31 | $0.04B | $-0.02B | -48.57% |
| 2011-12-31 | $0.03B | $-0.02B | -48.48% |
| 2011-09-30 | $0.03B | $-0.02B | -62.07% |
| 2011-06-30 | $0.03B | $-0.02B | -76.00% |
| 2011-03-31 | $0.02B | $-0.02B | -70.83% |
| 2010-12-31 | $0.02B | $-0.02B | -73.91% |
| 2010-09-30 | $0.02B | $-0.02B | -77.27% |
| 2010-06-30 | $0.02B | $-0.02B | -86.36% |
| 2010-03-31 | $0.02B | $-0.02B | -100.00% |
| 2009-12-31 | $0.02B | $-0.02B | -135.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.222B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.506B | 27.03 |
| Boston Scientific (BSX) | United States | $157.140B | 37.47 |
| Stryker (SYK) | United States | $149.815B | 30.50 |
| EssilorLuxottica (ESLOY) | France | $148.753B | 0.00 |
| Medtronic (MDT) | Ireland | $119.490B | 16.86 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.052B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.480B | 25.41 |
| ResMed (RMD) | United States | $42.323B | 30.27 |
| Agilent Technologies (A) | United States | $33.835B | 22.06 |
| GE HealthCare Technologies (GEHC) | United States | $33.726B | 15.85 |
| Terumo (TRUMY) | Japan | $27.731B | 32.86 |
| Koninklijke Philips (PHG) | Netherlands | $26.731B | 17.68 |
| Insulet (PODD) | United States | $23.441B | 78.54 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.941B | 13.33 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.385B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.798B | 28.64 |
| Lantheus Holdings (LNTH) | United States | $3.817B | 10.32 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.443B | 24.09 |
| Perrigo (PRGO) | Ireland | $3.255B | 8.13 |
| Prestige Consumer Healthcare (PBH) | United States | $3.201B | 14.20 |
| ICU Medical (ICUI) | United States | $3.045B | 20.73 |
| Haemonetics (HAE) | United States | $2.623B | 11.71 |
| LeMaitre Vascular (LMAT) | United States | $2.189B | 46.95 |
| QuidelOrtho (QDEL) | United States | $1.789B | 11.26 |
| Curaleaf Holdings (CURLF) | Canada | $1.750B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.687B | 72.46 |
| AdaptHealth (AHCO) | United States | $1.262B | 17.94 |
| Phibro Animal Health (PAHC) | United States | $1.262B | 16.14 |
| Acuren (TIC) | United States | $1.220B | 0.00 |
| Neogen (NEOG) | United States | $1.210B | 19.21 |
| BioLife Solutions (BLFS) | United States | $1.196B | 2496.00 |
| Tilray Brands (TLRY) | Canada | $1.167B | 0.00 |
| Valneva SE (VALN) | France | $0.979B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 8.30 |
| Kestra Medical Technologies (KMTS) | United States | $0.852B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.626B | 0.00 |
| SNDL (SNDL) | Canada | $0.581B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.557B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.535B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.61 |
| Surmodics (SRDX) | United States | $0.528B | 0.00 |
| Evolus (EOLS) | United States | $0.468B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.466B | 16.04 |
| CeriBell (CBLL) | United States | $0.425B | 0.00 |
| Owens & Minor (OMI) | United States | $0.412B | 3.66 |
| Sanuwave Health (SNWV) | United States | $0.338B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.303B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.290B | 0.00 |
| Omeros (OMER) | United States | $0.285B | 0.00 |
| Brainsway (BWAY) | Israel | $0.279B | 56.81 |
| Sanara MedTech (SMTI) | United States | $0.274B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.266B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.266B | 20.18 |
| High Tide (HITI) | Canada | $0.250B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.238B | 0.00 |
| Quanterix (QTRX) | United States | $0.228B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.212B | 0.00 |
| Organigram Global (OGI) | Canada | $0.201B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.194B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.47 |
| FitLife Brands (FTLF) | United States | $0.157B | 19.34 |
| Biote (BTMD) | United States | $0.147B | 4.87 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.10 |
| Jin Medical (ZJYL) | China | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Safety Shot (SHOT) | United States | $0.070B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 31.80 |
| Veru (VERU) | United States | $0.052B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 34.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.21 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.031B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |